Kenvue Inc. (NYSE: KVUE) is a prominent player in the consumer health industry, known for its wide range of health and wellness products. As of October 27, 2025, Jefferies has set a price target of $23 for KVUE, suggesting a potential increase of about 53.33% from its current price of $15. This optimistic outlook reflects confidence in the company's future performance.
KVUE is preparing to release its third quarter 2025 financial results on November 6, 2025. The announcement will be made before the market opens, followed by a conference call and webcast at 8:30 a.m. Eastern Time. This event will provide insights into the company's financial health and future prospects, which could influence investor sentiment.
Currently, KVUE's stock is priced at $15, showing a slight decrease of 0.60% with a change of $0.09. The stock has experienced fluctuations, with a daily low of $14.99 and a high of $15.28. Over the past year, KVUE has seen a high of $25.17 and a low of $14.05, indicating some volatility in its stock performance.
KVUE's market capitalization stands at approximately $28.79 billion, reflecting its significant presence in the market. The trading volume for the stock is 12.42 million shares on the NYSE, indicating active investor interest. As the company prepares to release its financial results, these metrics will be closely watched by investors and analysts alike.
